FRANKFURT (dpa-AFX) - The shares of Evonik continued to rise slightly on Tuesday afternoon. They recently gained 1.3 percent to €19.22 as the front-runner in a weak MDax.

They have now ended their temporary correction following the rally that began in mid-March. The highest level since May 2023, reached just under a week ago, is now within reach again.

In the morning, the chemical company's preliminary quarterly figures had put investors in a more positive mood. Analysts such as Chetan Udeshi from JPMorgan still see room for improvement in market expectations for 2024 following the stronger first quarter. Anil Shenoy from Barclays also considers the outlook for the year to be conservative./ajx/bek/mis